Author

Toshihiro Yamaguchi

Institution: SUWA Central Hospital

Observed institutions: Ministry of Health Labour and Welfare, Government of Japan, SUWA Central Hospital

ORCID: 0009-0009-5659-0138

Observed ORCID: 0009-0009-5659-0138

OpenAlex ID: A5060046521

Safety monitoring of COVID-19 vaccines in Japan

2022 · Toshihiro Yamaguchi, Masao Iwagami, et al. · The Lancet Regional Health - Western Pacific · 31

Tocilizumab (TCZ) for Giant Cell Arteritis: Clinical Outcomes Following Relapses and TCZ Discontinuation Due to Adverse Events

2024 · Fumika N. Nagase, Sho Fukui, et al. · The Journal of Rheumatology · 7

Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events

2022 · Hidetaka Kobayashi, Sayoko Fukuda, et al. · Therapeutic Innovation & Regulatory Science · 7

Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations

2022 · Toshihiro Yamaguchi, Masao Iwagami, et al. · The Lancet Regional Health - Western Pacific · 6

A feasible treatment strategy for tapering subcutaneous tocilizumab in giant cell arteritis: a 24-month multi-center retrospective study

2025 · Takanori Ito, Sho Fukui, et al. · Rheumatology International · 4

Performance of Diagnostic Examinations for Giant Cell Arteritis and Subtypes: A Multicenter Japanese Study

2025 · Nobuhiro Oda, Sho Fukui, et al. · International Journal of Rheumatic Diseases · 1

Anifrolumab as a glucocorticoid-sparing agent in MRI-negative myelitis associated with neuropsychiatric lupus: A case report

2025 · Masei Suda, Kouichi Dai, et al. · Modern Rheumatology Case Reports · 1

Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children

2023 · Toshihiro Yamaguchi, Masao Iwagami, et al. · The Lancet Regional Health - Western Pacific · 1

Works count: 8

Citation count: 58

H-index: 4

I10-index: 1